Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 3.64B | $ 3.50B | $ 3.54B | $ 2.33B | $ 2.32B |
Total Assets | $ 10.45B | $ 10.34B | $ 9.77B | $ 8.31B | $ 8.47B |
Total Debt | $ 4.31B | $ 4.10B | $ 4.45B | $ 4.35B | $ 3.44B |
Net Debt | $ 670.00M | $ 596.00M | $ 910.00M | $ 2.02B | $ 1.13B |
Total Liabilities | $ 7.92B | $ 7.89B | $ 7.13B | $ 6.73B | $ 6.57B |
Stockholders Equity | $ 2.53B | $ 2.44B | $ 2.64B | $ 1.58B | $ 1.90B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |